Clinical Development & Data
Trial architecture, endpoints, recruitment, comparator signals, investigator interpretation, and the way evidence in medical equipment will be read downstream.
Medical Equipment
ICG works across medical-equipment environments where installed base, procurement, workflow, service, interoperability, site economics, and clinical adoption must be read together.
The work includes medical-equipment market intelligence, imaging and clinical systems, infusion and medication platforms, automation, clinical-trial equipment, procurement, pricing, service architecture, and workflow adoption.
Installed Systems Create Structural Persistence.
Equipment markets are shaped by more than specifications. Installed base, capital cycles, procurement, service, training, integration, utilization, and switching costs create durable operating constraints.
ICG reconstructs those systems to show where adoption can occur, what must change inside the workflow, and how commercial and technical decisions reinforce one another.
Decision Environments
Engagements begin at different points, but the governing constraints often cross the boundaries of the initial request.
Regulatory & Access Pathways
Filing logic, label conditions, evidence requirements, reimbursement, pathway position, and country-level adoption constraints.
Launch & Commercial Architecture
Market preparation, field-force and medical roles, account coverage, channel structure, patient support, and launch sequencing.
Manufacturing & Delivery
Capacity, supply, configuration, administration, device or site readiness, and the relationship between operational uncertainty and asset value.
Patient & Treatment Systems
Patient identification, referral patterns, specialist pathways, administration burden, monitoring, persistence, and continuity of treatment.
Longitudinal Competitive Monitoring
Clinical, regulatory, access, organization, and commercial signals reconstructed across multi-phase and multi-year programs.
Evidence Architecture
The evidence base is developed through source calls and interviews positioned close to the decisions, constraints, and operating conditions being reconstructed.
Clinical & Investigator Side
Key opinion leaders, principal investigators, study-site personnel, treating specialists, centers of excellence, diagnostic pathways, and investigator-side clinical teams.
Company-Side Sources
Clinical development, regulatory, medical affairs, CMC and manufacturing, market access, patient services, field leadership, commercial, and portfolio functions.
Access & Operating Systems
Payer and reimbursement environments, procurement, distribution, treatment centers, testing providers, administration systems, patient-support infrastructure, and local access pathways.
Triangulation
Interview evidence is tested against clinical, regulatory, manufacturing, access, and organizational signals and against the criteria used by reviewers, payers, clinicians, partners, and other decision-makers.
Selected Project Record
Selected engagements across medical equipment.
The projects below are selected from a substantially larger body of work. They were chosen to illustrate different decision environments, lifecycle stages, modalities, geographies, and forms of engagement. The selection is illustrative rather than exhaustive. Multi-phase and longitudinal assignments may be presented as a single project title, and company, asset, or market details may be generalized where appropriate.
Imaging & Clinical Systems
- AI-Enabled Retinal Imaging and Clinical-Workflow Architecture in Ophthalmology
- Ophthalmic Imaging Platform and Workflow Assessment Across Retinal Diseases
- Digital-Pathology Adoption and Clinical-Workflow Architecture in Oncology
- Retinal-Imaging Algorithm and Specialist-Workflow Assessment
Infusion, Medication & Installed Systems
- Infusion-Pump and Medication-Automation Landscape in the United States
- Installed-Base and Procurement Assessment for Infusion Systems
- Medication-Automation Platform and Hospital-Workflow Landscape
- Service and Replacement-Cycle Assessment for Clinical Equipment
Procurement, Service & Market Architecture
- Clinical-Trial Equipment Pricing in France and the United States
- Commercial-Terms and Service Architecture for Clinical-Trial Equipment Providers
- Procurement and Utilization Assessment for Flow-Cytometry Systems
- Cross-Market Pricing Architecture for Clinical Equipment and Associated Services
Medical Equipment Engagements
ICG can enter at the level of a single critical question, a multi-market evidence program, or a longitudinal clinical, regulatory, manufacturing, access, commercial, or operating-system decision environment.